RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Fibrogen Inc patents

Recent patent applications related to Fibrogen Inc. Fibrogen Inc is listed as an Agent/Assignee. Note: Fibrogen Inc may have other listings under different names/spellings. We're not affiliated with Fibrogen Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Fibrogen Inc-related inventors




Date Fibrogen Inc patents (updated weekly) - BOOKMARK this page
02/09/17Novel nitrogen-containing heteroaryl compounds and methods of use thereof
02/02/17Methods for treating idiopathic pulmonary fibrosis
11/17/16Crystalline forms of a prolyl hydroxylase inhibitor
09/08/16Connective tissue growth factor antibodies
07/07/16Process for making isoquinoline compounds
06/09/16Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase
05/05/16Pharmaceutical formulations of a hif hydroxylase inhibitor
01/28/16Connective tissue growth factor antibodies
01/14/16Cyanoisoquinoline compounds and methods of use thereof
01/07/16Crystalline forms of -acetic acid
12/31/15Treatment lung remodeling diseases
11/12/15Crystalline forms of a prolyl hydroxylase inhibitor
09/03/15Enhanced erythropoiesis and iron metabolism
07/30/15Isothiazole-pyridine derivatives as modulators of hif (hypoxia inducible factor) activity
07/30/15Therapeutic pancreatic cancer
07/02/15Thiochromene derivatives as hif hydroxylase inhibitors
06/25/15Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase
06/25/15Process for making isoquinoline compounds
05/28/15Therapeutic methods for peritoneal carcinomatosis
05/07/15Methods for treating anemia
03/26/15Methods for treating idiopathic pulmonary fibrosis
03/19/15Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylase
02/05/154 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors
02/05/15Crystalline forms of a prolyl hydroxylase inhibitor
01/29/15Cyanoisoquinoline compounds and methods of use thereof
01/15/15Treatment for high cholesterol
12/04/14Methods for treatment of muscular dystrophy
08/07/14Novel thienopyridine compounds, and methods of use thereof
07/03/14Connective tissue growth factor antisense oligonucleotides
06/19/14Methods for increasing reticulocyte hemoglobin content
06/12/14Methods for reducing blood pressure
03/27/14Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase
03/13/14Connective tissue growth factor antibodies
03/06/14Compositions and methods for treating brain tumors
09/19/13Stabilization of hypoxia inducible factor (hif) alpha
08/15/13Treatments for cancer
08/08/13Methods for treating anemia using inhibitors of hypoxia-inducible factor (hif) hydroxylase
07/11/13Novel nitrogen-containing heteroaryl compounds and methods of use thereof
07/11/13Connective tissue growth factor antisense oligonucleotides
09/27/12Treatment for radiation-induced disorders
07/12/12Cyanoisoquinoline compounds and methods of use thereof
06/28/12Methods for treatment of muscular dystrophy
06/14/12Methods for improving kidney function
02/16/12Vascular disease therapies
02/02/12Novel nitrogen-containing heteroaryl compounds and methods of use thereof
12/15/11Thiochromene derivatives as hif hydroxylase inhibitors
10/27/11Methods for treatment of multiple sclerosis
10/27/11Compounds and methods for treatment of stroke
09/01/11Cyanoisoquinoline compounds and methods of use thereof
08/25/11Method for producing double-crosslinked collagen
07/07/11Stabilization of hypoxia inducible factor (hif) alpha
07/07/11Methods for treating anemia using inhibitors of hypoxia-inducible factor (hif) hydroxylase
04/21/11Connective tissue growth factor antibodies
02/17/11Methods for increasing endothelial progenitor cells
01/20/11Compounds and methods for treatment of cancer-related anemia
12/30/10Isothiazole-pyridine derivates as modulators of hif (hypoxia inducible factor) activity
12/30/10Treatment anemia
12/30/10Chromene derivatives and use thereof as hif hydroxylase activity inhibitors
12/02/10Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions
11/18/10Diabetic nephropathy therapies
08/12/10Compounds and methods for treatment of chemotherapy-induced anemia
07/01/10Fat regulation
06/10/10Methods for inhibiting t helper cell differentiation
02/25/10Compounds and methods for their use
12/31/09Diagnostic marker for diabetic vascular complications
Patent Packs
06/04/09Recombinant gelatins







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Fibrogen Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Fibrogen Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';